• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冷冻保护剂对人碳酸酐酶II-乙酰唑胺复合物结构和热稳定性的影响。

Effects of cryoprotectants on the structure and thermostability of the human carbonic anhydrase II-acetazolamide complex.

作者信息

Aggarwal Mayank, Boone Christopher D, Kondeti Bhargav, Tu Chingkuang, Silverman David N, McKenna Robert

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, 1600 SW Archer Road, PO Box 100245, Gainesville, FL 32610, USA.

出版信息

Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):860-5. doi: 10.1107/S0907444913002771. Epub 2013 Apr 19.

DOI:10.1107/S0907444913002771
PMID:23633596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3640473/
Abstract

Protein X-ray crystallography has seen a progressive shift from data collection at cool/room temperature (277-298 K) to data collection at cryotemperature (100 K) because of its ease of crystal preparation and the lessening of the detrimental effects of radiation-induced crystal damage, with 20-25%(v/v) glycerol (GOL) being the preferred choice of cryoprotectant. Here, a case study of the effects of cryoprotectants on the kinetics of carbonic anhydrase II (CA II) and its inhibition by the clinically used inhibitor acetazolamide (AZM) is presented. Comparative studies of crystal structure, kinetics, inhibition and thermostability were performed on CA II and its complex with AZM in the presence of either GOL or sucrose. These results suggest that even though the cryoprotectant GOL was previously shown to be directly bound in the active site and to interact with AZM, it affects neither the thermostability of CA II nor the binding of AZM in the crystal structure or in solution. However, addition of GOL does affect the kinetics of CA II, presumably as it displaces the water proton-transfer network in the active site.

摘要

由于易于制备晶体以及减少辐射诱导的晶体损伤的有害影响,蛋白质X射线晶体学已逐渐从在低温/室温(277 - 298 K)下收集数据转向在低温(100 K)下收集数据,20 - 25%(v/v)的甘油(GOL)是首选的冷冻保护剂。在此,展示了一个关于冷冻保护剂对碳酸酐酶II(CA II)动力学及其被临床使用的抑制剂乙酰唑胺(AZM)抑制的影响的案例研究。在存在GOL或蔗糖的情况下,对CA II及其与AZM的复合物进行了晶体结构、动力学、抑制作用和热稳定性的比较研究。这些结果表明,尽管冷冻保护剂GOL先前已被证明直接结合在活性位点并与AZM相互作用,但它既不影响CA II的热稳定性,也不影响AZM在晶体结构或溶液中的结合。然而,添加GOL确实会影响CA II的动力学,推测是因为它取代了活性位点中的水质子转移网络。

相似文献

1
Effects of cryoprotectants on the structure and thermostability of the human carbonic anhydrase II-acetazolamide complex.冷冻保护剂对人碳酸酐酶II-乙酰唑胺复合物结构和热稳定性的影响。
Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):860-5. doi: 10.1107/S0907444913002771. Epub 2013 Apr 19.
2
High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design.人碳酸酐酶II与乙酰唑胺复合物的高分辨率结构为抑制剂药物设计提供了见解。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Oct 1;65(Pt 10):992-5. doi: 10.1107/S1744309109036665. Epub 2009 Sep 25.
3
Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.噻吩尾在乙酰胺唑骨架中的引入对人碳酸酐酶同工酶 I、II、IX 和 XII 的抑制作用。
Bioorg Med Chem Lett. 2013 Oct 15;23(20):5646-9. doi: 10.1016/j.bmcl.2013.08.019. Epub 2013 Aug 13.
4
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.来自致病性细菌霍乱弧菌的四聚体型IIβ-碳酸酐酶的晶体结构和动力学研究。
Acta Crystallogr D Biol Crystallogr. 2015 Dec 1;71(Pt 12):2449-56. doi: 10.1107/S1399004715018635. Epub 2015 Nov 26.
5
Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.碳酸酐酶抑制剂。唑尼沙胺是胞质同工酶II和线粒体同工酶V的有效抑制剂:溶液和X射线晶体学研究。
Bioorg Med Chem Lett. 2005 May 2;15(9):2315-20. doi: 10.1016/j.bmcl.2005.03.032.
6
Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding.乙酰唑胺结合人碳酸酐酶 II 的中子衍射揭示了药物结合的原子细节。
J Am Chem Soc. 2012 Sep 12;134(36):14726-9. doi: 10.1021/ja3068098. Epub 2012 Sep 4.
7
Competitive inhibitory effects of acetazolamide upon interactions with bovine carbonic anhydrase II.乙酰唑胺对与牛碳酸酐酶II相互作用的竞争性抑制作用。
Protein J. 2007 Sep;26(6):371-85. doi: 10.1007/s10930-007-9073-4.
8
Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design.针对增强抑制剂设计的人碳酸酐酶相互作用的热力学、动力学和结构参数化。
Q Rev Biophys. 2018 Jan;51:e10. doi: 10.1017/S0033583518000082.
9
Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide.淋病奈瑟菌碳酸酐酶的晶体结构及其与抑制剂乙酰唑胺的复合物
J Mol Biol. 1998;283(1):301-10. doi: 10.1006/jmbi.1998.2077.
10
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.铜绿假单胞菌II型β-碳酸酐酶psCA3的结构与抑制研究
Bioorg Med Chem. 2015 Aug 1;23(15):4831-4838. doi: 10.1016/j.bmc.2015.05.029. Epub 2015 Jun 8.

引用本文的文献

1
Hidden targets in dermatology: and inhibitory effects of common 23 dermatologic drugs on human carbonic anhydrase isoenzymes I and II.皮肤科中的潜在靶点:23种常见皮肤科药物对人碳酸酐酶同工酶I和II的抑制作用
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2540935. doi: 10.1080/14756366.2025.2540935. Epub 2025 Aug 5.
2
Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity.含有双三唑部分的新型苯磺酰胺,具有选择性碳酸酐酶抑制作用和抗癌活性。
RSC Med Chem. 2024 Oct 4;16(1):324-45. doi: 10.1039/d4md00617h.
3
Structural insight into activity enhancement and inhibition of H64A carbonic anhydrase II by imidazoles.咪唑类化合物增强和抑制 H64A 碳酸酐酶 II 活性的结构研究。
IUCrJ. 2014 Feb 28;1(Pt 2):129-35. doi: 10.1107/S2052252514004096. eCollection 2014 Mar 1.
4
Carbonic anhydrases and their biotechnological applications.碳酸酐酶及其生物技术应用。
Biomolecules. 2013 Aug 19;3(3):553-62. doi: 10.3390/biom3030553.
5
Structural, catalytic and stabilizing consequences of aromatic cluster variants in human carbonic anhydrase II.人碳酸酐酶 II 中芳香族簇变体的结构、催化和稳定化作用。
Arch Biochem Biophys. 2013 Nov 1;539(1):31-7. doi: 10.1016/j.abb.2013.09.001. Epub 2013 Sep 10.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Structural annotation of human carbonic anhydrases.人类碳酸酐酶的结构注释。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):267-77. doi: 10.3109/14756366.2012.737323. Epub 2012 Nov 9.
3
Insights towards sulfonamide drug specificity in α-carbonic anhydrases.探索磺酰胺类药物在α-碳酸酐酶中的特异性。
Bioorg Med Chem. 2013 Mar 15;21(6):1526-33. doi: 10.1016/j.bmc.2012.08.019. Epub 2012 Aug 28.
4
Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding.乙酰唑胺结合人碳酸酐酶 II 的中子衍射揭示了药物结合的原子细节。
J Am Chem Soc. 2012 Sep 12;134(36):14726-9. doi: 10.1021/ja3068098. Epub 2012 Sep 4.
5
Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).碳酸酐酶抑制剂更新:专利研究综述(2008-2011)。
Expert Opin Ther Pat. 2012 Aug;22(8):903-15. doi: 10.1517/13543776.2012.707646. Epub 2012 Jul 13.
6
Can radiation damage to protein crystals be reduced using small-molecule compounds?使用小分子化合物能否减少辐射对蛋白质晶体的损伤?
Acta Crystallogr D Biol Crystallogr. 2011 Oct;67(Pt 10):881-93. doi: 10.1107/S0907444911032835. Epub 2011 Sep 8.
7
Accessing protein conformational ensembles using room-temperature X-ray crystallography.利用室温 X 射线晶体学获取蛋白质构象组。
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16247-52. doi: 10.1073/pnas.1111325108. Epub 2011 Sep 14.
8
Perspectives on carbonic anhydrase.碳酸酐酶的观点。
Comp Biochem Physiol A Mol Integr Physiol. 2010 Nov;157(3):193-7. doi: 10.1016/j.cbpa.2010.06.161. Epub 2010 Jun 9.
9
De-icing: recovery of diffraction intensities in the presence of ice rings.除冰:在存在冰环的情况下恢复衍射强度。
Acta Crystallogr D Biol Crystallogr. 2010 Jun;66(Pt 6):741-4. doi: 10.1107/S0907444910012436. Epub 2010 May 15.
10
A short, strong hydrogen bond in the active site of human carbonic anhydrase II.人碳酸酐酶 II 活性部位的短而强氢键。
Biochemistry. 2010 Jan 19;49(2):249-51. doi: 10.1021/bi902007b.